Can medications (antipyretics or antivirals) cause body temperature to fall below normal after a fever?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Medications that reduce fever—antipyretics such as acetaminophen (paracetamol) and NSAIDs—can, in documented cases, drive body temperature below the normal range after or during a febrile illness, particularly in children and vulnerable patients; this phenomenon has been described in case reports and experimental models [1] [2] [3]. Available reporting contains no clear evidence that antivirals commonly cause clinically significant hypothermia; the literature provided does not cover antivirals, so that question remains unanswered by these sources.
1. Antipyretics and documented post‑fever hypothermia: case reports and reviews
Multiple case series and literature reviews report children becoming hypothermic after therapeutic doses of antipyretics, with temperatures measured well below normal following standard paracetamol or combination paracetamol/ibuprofen regimens; one paediatric case was initially misdiagnosed as “cold sepsis” before antipyretic‑induced hypothermia was concluded to be most likely [1] [2] [4].
2. Experimental biology supports a drug effect on thermoregulation
Animal and mechanistic studies show that acetaminophen can lower core temperature through actions on prostaglandin pathways in the brain—acetaminophen produced hypothermia in mice with changes in brain PGE2 concentrations and differential effects in COX‑1/COX‑2 knockout animals—supporting a plausible biological mechanism for drug‑induced cooling beyond simple fever suppression [3].
3. Who is at risk and how common is it?
The phenomenon appears uncommon but is repeatedly reported in young children and in certain vulnerable groups (reports cite febrile children, patients with HIV or stroke in small series), and may be more likely when antipyretics are combined or given regularly rather than as single agents; national guidelines generally advise single‑agent use because additive effects have been suggested [1] [4].
4. Antivirals: an evidence gap in the supplied reporting
The assembled sources do not provide evidence that antiviral drugs themselves induce hypothermia after fever; none of the cited reviews or case reports discuss antivirals as causal agents, so no affirmative claim about antivirals can be made from these materials and that remains an open question requiring dedicated pharmacovigilance data or trial evidence (limitation: [1]–[1]4).
5. Clinical significance and hazards: misdiagnosis and downstream consequences
When antipyretic‑related hypothermia occurs it can create a diagnostic trap—patients have been worked up invasively for sepsis or cold exposure—because hypothermia is itself a clinical red flag; the literature warns clinicians to consider recent antipyretic dosing and the pattern of findings before pursuing aggressive invasive tests [1] [2].
6. Antipyretics vs deliberate hypothermia and outcome data
Larger bodies of research separate pharmacologic fever control from formal therapeutic hypothermia: antipyretic use has not been shown to improve clinical outcomes in infections and, where hypothermia is deliberately induced, outcomes have in some trials been worse—illustrating that lowering temperature is not uniformly benign and that drug‑induced cooling may have unintended consequences in critically ill patients [5] [6].
7. Nuance, competing interpretations and hidden biases
Observational ICU data link low temperatures and antipyretic treatments with complex mortality signals—some analyses find no mortality benefit and possible harm in certain temperature strata—so there is an implicit clinical and research agenda debating permissive fever versus aggressive cooling, which colors reporting and guideline recommendations about when to use antipyretics [7] [8]. Case reports can over‑represent rare harms and under‑represent denominator data, so frequency estimates remain uncertain [1] [2].
8. Practical takeaway and remaining uncertainties
Concisely: antipyretics can, in documented cases and with biological plausibility, reduce temperature below normal after a fever—especially with combination or regular dosing in children or vulnerable patients—and clinicians should be alert to recent dosing to avoid misdiagnosis [1] [3] [4]; the data provided do not permit conclusions about antivirals and do not precisely quantify risk, so further pharmacovigilance and larger observational studies are needed to define incidence and clinical impact (limitation: [1]–[1]4).